T. Rowe Price Health Care ETF (TMED) is an ETF managed by T. Rowe Price. Its largest position is ELI LILLY & Co (LLY), representing 14.48% of fund assets.
T. Rowe Price Health Care ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- TMED
- Type:
- ETF
- Manager:
- T. Rowe Price
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- May 28, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
ELI LILLY & Co
|
14.48% | $2,933,146.53 | 3,189 |
|
-
UNITEDHEALTH GROUP INC
|
6.54% | $1,325,349.82 | 4,898 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
4.59% | $930,466.29 | 1,893 |
|
-
GILEAD SCIENCES, INC.
|
4.14% | $839,007.40 | 6,020 |
|
-
ABBOTT LABORATORIES
|
3.91% | $792,612.40 | 7,720 |
|
-
DANAHER CORP /DE/
|
2.73% | $553,252.80 | 2,918 |
|
-
Medtronic plc
|
2.24% | $454,479.25 | 5,245 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.06% | $417,557.94 | 1,262 |
|
-
STRYKER CORP
|
2.00% | $405,808.65 | 1,235 |
|
-
Dyne Therapeutics, Inc.
|
1.88% | $380,167.97 | 20,969 |
|
-
WATERS CORP /DE/
|
1.75% | $354,977.60 | 1,192 |
|
-
BECTON DICKINSON & CO
|
1.71% | $346,220.46 | 2,202 |
|
-
AGILENT TECHNOLOGIES, INC.
|
1.69% | $341,484.08 | 2,996 |
|
-
Elanco Animal Health Inc
|
1.59% | $321,332.04 | 13,428 |
|
-
HUMANA INC
|
1.57% | $318,170.65 | 1,835 |
|
-
CYTOKINETICS INC
|
1.54% | $311,227.02 | 4,722 |
|
-
WEST PHARMACEUTICAL SERVICES INC
|
1.48% | $300,266.72 | 1,198 |
|
-
BOSTON SCIENTIFIC CORP
|
1.47% | $297,748.75 | 4,745 |
|
-
Ascendis Pharma A/S
|
1.39% | $282,481.55 | 1,235 |
|
-
BIOGEN INC.
|
1.26% | $254,828.70 | 1,390 |
|
-
Vaxcyte, Inc.
|
1.19% | $240,342.96 | 4,136 |
|
-
Immunome Inc.
|
1.15% | $233,331.03 | 10,669 |
|
-
METTLER TOLEDO INTERNATIONAL INC/
|
1.11% | $224,493.60 | 178 |
|
-
Cencora, Inc.
|
1.06% | $215,185.90 | 685 |
|
-
APELLIS PHARMACEUTICALS INC
|
1.03% | $207,667.26 | 5,162 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.02% | $206,294.88 | 267 |
|
-
DEXCOM INC
|
1.01% | $204,162.80 | 3,251 |
|
-
CVS HEALTH Corp
|
0.96% | $193,770.36 | 2,698 |
|
-
MoonLake Immunotherapeutics
|
0.89% | $181,162.16 | 9,719 |
|
-
INSULET CORP
|
0.83% | $168,501.52 | 803 |
|
-
Adaptive Biotechnologies Corp
|
0.83% | $167,725.92 | 12,084 |
|
-
Bicara Therapeutics Inc.
|
0.82% | $165,285.90 | 8,310 |
|
-
BioNTech SE
|
0.80% | $162,561.52 | 1,829 |
|
-
Immatics N.V.
|
0.79% | $161,061.12 | 16,368 |
|
-
REPLIGEN CORP
|
0.79% | $160,117.38 | 1,359 |
|
-
COOPER COMPANIES, INC.
|
0.78% | $157,085.50 | 2,197 |
|
-
Shattuck Labs, Inc.
|
0.77% | $155,033.73 | 24,111 |
|
-
IDEXX LABORATORIES INC /DE
|
0.74% | $149,462.74 | 266 |
|
-
Xenon Pharmaceuticals Inc.
|
0.73% | $148,747.70 | 2,558 |
|
-
Sarepta Therapeutics, Inc.
|
0.73% | $148,337.92 | 6,817 |
|
-
BRISTOL MYERS SQUIBB CO
|
0.73% | $147,500.80 | 2,432 |
|
-
MOLINA HEALTHCARE, INC.
|
0.71% | $144,230.60 | 1,082 |
|
-
APOGEE THERAPEUTICS INC
|
0.69% | $139,553.86 | 1,658 |
|
-
CG Oncology, Inc.
|
0.68% | $137,255.04 | 2,028 |
|
-
AGIOS PHARMACEUTICALS, INC.
|
0.65% | $132,139.98 | 3,906 |
|
-
INCYTE CORP
|
0.65% | $131,579.76 | 1,398 |
|
-
Kymera Therapeutics, Inc.
|
0.62% | $124,685.13 | 1,497 |
|
-
NOVO NORDISK A S
|
0.58% | $117,600.00 | 3,200 |
|
-
Cabaletta Bio, Inc.
|
0.58% | $117,364.70 | 43,630 |
|
-
ALIGN TECHNOLOGY INC
|
0.54% | $108,686.62 | 634 |
Advertisement (320x50)